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Kar et al . raise three issues witi regard to our recent report (1) . The
first is the safety of peak and mean coronary venous pressures
during retroperfusion . The definition of "mean" coronary venous
pressure must be clarified because previous studies (2-5) did not
differentiate between mean diastolic or systolic pressures . With
regard to the data from our article, mean coronary venous pressure
was not 61 mm Hg, as stated by Kar et al ., but 50 mm Hg in the
animals treated by synchronized retroperfusion, and it was only
34 mm Hg in the animals treated by selective suction and retroin-
fusion. Furthermore, obstructipn of the great cardiac vein by
the
S,5F retrroperfilsion catheter was excluded by previous determina-
tion of the rest pressures using a 3F catheter . In a previous report
(6), we stated that 50 mm Hg was the suggested limit of coronary
venous peak pressure by others
(2-4) . In these studies the suggested
safety limits for long-term application (several hours) were derived
from the experience of studies without adequate coronary venous
drainage (7,8)
but were not actually caused by inducing damage
related to certain coronary venous pressures, Hence, the observa-
tion that using a limit of 50 or 60 mm Hg for peak or 40 mm Hg for
mean coronary venous
pressures was safe in experimental (2-4,6)
and clinical studies (5,9-t0) does not necessarily imply that higher
pressures are harmful, in particular with regard
to short•term
(sever minutes) application of retroinfusion, as demonstrated
in
our study
. Furthermore, differences with regard to coronary venous
wall stress may occur if pressure is reduced to zero intermittently by
active suction during selective suction and retroinfusion compared
with synchronized retroperfusion
. Therefore, definitive upper safety
limits for peak and mean coronary venous pressures in short- and
long-term applications of coronary venous retroinfusion--in our
opinion--are not yet clear, as stated by Kar et al
.
The second issue is the feasibility of the selective suction and
retroinfusion technique
. It has been shown by several studies that
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the main difficulty using retroinfusion techniques was to enter the
coronary sinus but not to advance into the great cardiac vein
(5,9,10)
. Therefore, we don't believe that the selective suction and
retroinfusion technique will be snore tithe-consuming than synchro-
nized retroperfusion, which is also supported by the fact that smaller
catheter sizes used for selective suction and retroinfusion should
make it easier to advance it into the smaller veins
.
The third issue is the clinical efficacy of selective suction and
retroinfusion and synchronized retroperfusion . Because our study
was preclinicat, we did not intend to anticipate any clinical conclu-
sion
. Our experimental results, however, suggest that selective
suction and retroinfusion may indeed be more effective than syn-
chronized retroperfusion in pigs. The finding of clearly superior
preservation of regional myocardial function by selective suction
and retroinfusion compared with synchronized retroperfusion (71%
vs. 7% of baseline value) during the first minute of arterial occlusion
suggests the clinical relevance of myocardial protection by selective
suction and retroinfusion for application during short-term repeated
percutaneous transluminal coronary angioplasty as well . Myocardial
oxygen tension and regional myocardial function appeared to be
more relevant variables for comparing the efficacy of selective
suction and retroinfusion and synchronized retroperfusion in an
experimental model of coronary angioplasty than the development
of myocardial necrosis . Furthermore, we did not simulate myocar-
dial infarction in ibis study because the efficacy of selective suction
and retroinfusion in reducing myocardial necrosis has been demon-
strated previously (6) .
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Myocardial ys unctio i Active
Rheumatic Cardatis
The recent report by Essop et al . (1) from South Africa found no
echocardiographic evidence of left ventricular myocardial dysfunc-
tion in 32 young patients (mean age 14 years) with active rheumatic
carditis and congestive failure . All had isolated mitral regurgitation
or combined mitral and aortic regurgitation . Echocardiographic
studies were completed before and after prosthetic mitral or mitral
and aortic valve replacement . Preoperatively, the percent fractional
shortening was increased, and both left ventricular systolic and
diastolic dimensions were increased . After surgical restoration of
valvular competence, left ventricular measurements returned to
normal, and the increased fractional shortening returned to control
values .
This study is at marked variance with the time-honored concept
taught for decades that myocardilis and not mitral regurgitation was
the cause of cardiac enlargement and congestive heart failure in
children with acute rheumatic carditis . This concept had consider-
able clinical support because those patients -who slowly recovered
from severe carditis were usually left with significant mitral regur-
gitation, which, in turn, was remarkably well tolerated for years .
When patients did succumb from what was considered to be "toxic
rheumatic myocarditis," at autopsy the mitral valve appeared
remarkably benign with minimal edema and some marginal vegeta-
tions. There was no contracture of the mitral leaflets or of the
chordae that would have permitted significant mitral regurgitation .
On the other hand, these patients had histologic confirmation of
myocarditis with the presence of Ascholf bodies and infiltrates .
Thus, the conclusion was well supported both by clinical experience
and findings at autopsy .
When echocardiography became available, studies conducted in
South Africa revealed a totally different cause of mitral regurgita-
tion, which was found to be due to a combination of annular dilation
and chordal elongation of the anterior leaflet (2) . The chordal
elongation caused the apposing edge of the anterior leaflet to
prolapse into the left atrium, allowing mitral regurgitation with a
characteristic jet striking the posterior wall of the left atrium . Witin
increasing prolapse, the anterior leaflet could actually become flail,
permitting massive mitral regurgitation . (Chordal elongation noted
in earlier postmortem examination was misinterpreted as a compen-
satory response to left ventricular dilation [3j .)
The decision to restore valvular competence, either by valvulo-
plasty or valve replacement in the face of active carditis was indeed
a bold step forward . However, nearly all of these patients experi-
enced a rapid and often dramatic improvement, seriously challeng-
ing the concept of myocarditis being responsible for cardiac failure
(4) . The well designed and adequately controlled study of Essop et
al. (1) supports the extensive clinical experience in South Africa (5)
as well as the limited experience in France (6) and the United States
(7) . The overall experience over the past 10 years quite emphatically
disproves the concept that congestive failure in active rheumatic
carditis is due to myocardial dysfunction .
The Editorial Comment by the highly respected Drs, Edwards (8)
was extremely disappointing . Rather than truly addressing the
question, "Congestive heart failure in rheumatic carditis ; valvular
or myocardial in origin?," their
comments were directed toward the
difficulty determining whether the active carditis represented the
initial or a recurrent episode . Begging the question in this manner is
totally irrelevant because it makes little difference whether the
active carditis is the first, second or third episode of rheumatic
activity . The answer should have been, and clearly is, that mitral or
mitral and aortic regurgitation, not myocarditis, is the cause of
congestive failure in active rheumatic carditis in young patients .
Rheumatic fever is not a big problem in our country, and,
fortunately, severe fulminant active rheumatic carditis is extremely
rare, Even so, it is time to incorporate the extensive experience and
new understanding provided by our South African colleagues in out -
consideration of this persistent problem .
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Reply
The comments of Veasy are of interest . 11 is indeed correct that in
the presurgical era, some patients with severe carditis and conges-
tive heart failure were able to make sufficient recovery to be at lc to
tolerate underlying mitral regurgitation for many years . This does
not, however, necessarily imply that the observed improvement
reflected an amelioration of myocarditis with consequent improve-
ment in left ventricular contractile function . An equally plausible
explanation would relate clinical improvement to temporal changes
in ventricular loading conditions, with transformation of acute mitral
regurgitation to a subacute or chronic compensated form . The latter,
whether of rheumatic or other etiology, may be tolerated for
considerable periods of time . The patients included in our study
comprised a group with such severe degrees of mitral regurgitation
that despite cessation of physical activity and optimal pharmaco-
logic therapy, heart failure remained refractory, necessitating sur-
gical intervention .
As pointed out by Veasy, the relatively normal gross appearance
of the mitral valve at surgery is beguiling, Inability to appreciate
spatial relations and leaflet coaptation margins in the flaccid non-
LETTERS TO THE EDITOR
591
